Drug Profile
Measles, mumps and rubella vaccine - Merck
Alternative Names: M-M-RVAXPRO; MMR vaccine - Sanofi PasteurLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator sanofi pasteur MSD
- Developer Sanofi Pasteur
- Class Measles vaccines; Rubella vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Measles; Mumps; Rubella
Most Recent Events
- 24 Jan 2019 Measles, mumps and rubella vaccine is not yet available in Liechtenstein (IM, SC)
- 02 Jan 2017 Sanofi Pasteur MSD ended their joint venture and will separately pursue their vaccine strategies in Europe